Publications

Journal Article
Review
Ppublish 1 citations
Electronic publication date
November 16, 2023

View on Pubmed.gov 37970130 | View on doi.org 10.4239/wjd.v14...

Role of glycolysis in diabetic atherosclerosis.

Search for publications in this journal World J Diabetes - 14(10):1478-1492

  • Qian-Jia Liu

    Search for this expert
    1
  • Wei Yuan

    Search for this expert
    1
  • Ping Yang

    Search for this expert
    1
  • Chen Shao 2

Abstract

Diabetes mellitus is a kind of typical metabolic disorder characterized by elevated blood sugar levels. Atherosclerosis (AS) is one of the most common complications of diabetes. Modern lifestyles and trends that promote overconsumption and unhealthy practices have contributed to an increase in the annual incidence of diabetic AS worldwide, which has created a heavy burden on society. Several studies have shown the significant effects of glycolysis-related changes on the occurrence and development of diabetic AS, which may serve as novel thera-peutic targets for diabetic AS in the future. Glycolysis is an important metabolic pathway that generates energy in various cells of the blood vessel wall. In particular, it plays a vital role in the physiological and pathological activities of the three important cells, Endothelial cells, macrophages and vascular smooth muscle cells. There are lots of similar mechanisms underlying diabetic and common AS, the former is more complex. In this article, we describe the role and mechanism underlying glycolysis in diabetic AS, as well as the therapeutic targets, such as trained immunity, microRNAs, gut microbiota, and associated drugs, with the aim to provide some new perspectives and potentially feasible programs for the treatment of diabetic AS in the foreseeable future.

References

Int J Mol Sci. 2021 Jul 15;22(14):

Nutrients. 2021 Dec 30;14(1):

Science. 2016 Apr 22;352(6284):aaf1098

Nat Microbiol. 2018 Dec;3(12):1461-1471

Cited by 1 citations (total)

Journal Article Review

Trained immunity in diabetes: emerging targets for cardiovascular complications.

Electronic publication date May 29, 2025

Search for publications in this journal Front Endocrinol (Lausanne)

Yanan Bai [...] Weixiong Jian et al.

Diabetes is a metabolic disorder primarily characterized by persistent hyperglycemia. Diabetes-induced inflammation significantly compromises cardiovascular health, greatly increasing the risk...

Conflict of interest statement

Conflict-of-interest statement: The authors declare no conflict of interest.

MeSH

Specialties

Copyright

©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.